The FDA Calls Kyowa Hakko Kirin's Lymphoma Drug a Breakthrough Post author:Sam Post published:August 24, 2017 Post category:BioPharma August 25, 2017By Alex Keown, BioSpace.com Breaking News Staff<BR… Source: BioSpace You Might Also Like Baxter International To Host First Quarter 2017 Financial Results Conference Call For Investors March 22, 2017 <b>Aviva</b> Invests In Owlstone Medical Breath Biopsy Platform March 26, 2017 Epizyme Falls as Investors Take in Disappointing Phase II Data June 14, 2017
Baxter International To Host First Quarter 2017 Financial Results Conference Call For Investors March 22, 2017
